GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 189 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,856,000 | -27.3% | 112,100 | 0.0% | 0.22% | +50.0% |
| Q2 2021 | $3,926,000 | -35.8% | 112,100 | -25.3% | 0.15% | -36.0% |
| Q1 2021 | $6,113,000 | +35.3% | 150,000 | +43.8% | 0.23% | -1.7% |
| Q4 2020 | $4,517,000 | +233.1% | 104,300 | +247.7% | 0.23% | +91.7% |
| Q2 2018 | $1,356,000 | +38.4% | 30,000 | +47.8% | 0.12% | +27.4% |
| Q1 2018 | $980,000 | -0.4% | 20,300 | -18.8% | 0.10% | -1.0% |
| Q4 2017 | $984,000 | – | 25,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |